EMOR (Healixa) PEG Ratio: N/A (As of Jun. 27, 2026)


What is Healixa PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Healixa's PE Ratio without NRI is . Healixa's 5-Year EBITDA growth rate is 0.00%. Therefore, Healixa's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Healixa's PEG Ratio or its related term are showing as below:



EMOR's PEG Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.35
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Healixa  (OTCPK:EMOR) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Healixa PEG Ratio Related Terms


Healixa PEG Ratio Historical Data

* Premium members only.

The historical data trend for Healixa's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healixa PEG Ratio Chart

Healixa Annual Data
Trend
PEG Ratio

Healixa Quarterly Data
PEG Ratio

Healixa PEG Ratio Competitor Comparison

For the Health Information Services subindustry, Healixa's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healixa PEG Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Healixa's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Healixa's PEG Ratio falls into.



Healixa PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Healixa's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Healixa Business Description

Address 273 Knickerbocker Avenue, Bohemia, New York, NY, USA, 11716
Healixa Inc is a technology company focused on building and acquiring disruptive technologies in the health-tech, clean water harvesting, and green-tech industries. Its activities consist mainly of research and development, intellectual property development, engineering validation, pilot deployment, and early-stage commercialization of its technology platforms. The company also focuses on clean water through its Eternal Spring Deposition Water Harvesting technology and on water harvesting and thermal cooling technologies.